May 20, 2021 Update Dear Neighbours, I Would Like To

Total Page:16

File Type:pdf, Size:1020Kb

May 20, 2021 Update Dear Neighbours, I Would Like To May 20, 2021 Update Dear Neighbours, I would like to continue to thank everyone for their efforts during these difficult times. It has been difficult for everyone. We must continue to fight the spread of COVID-19 and keep ourselves and our community safe by following the public health measures in place. Remember, our mental health is paramount, we need to continue to take care of ourselves and seek support if needed. *NEW* Today, the Ontario government released its three-step Roadmap to Safely Reopen the Province. Roadmap to Reopen outlines three steps to easing public health measures, guided by the following principles: • Step One An initial focus on resuming outdoor activities with smaller crowds where the risk of transmission is lower, and permitting retail with restrictions. This includes allowing outdoor gatherings of up to 10 people, outdoor dining with up to four people per table and non-essential retail at 15 per cent capacity. • Step Two Further expanding outdoor activities and resuming limited indoor services with small numbers of people where face coverings are worn. This includes outdoor gatherings of up to 25 people, outdoor sports and leagues, overnight camps, personal care services where face coverings can be worn and with capacity limits, as well as indoor religious services, rites or ceremony gatherings at 15 per cent capacity. • Step Three Expanding access to indoor settings, with restrictions, including where there are larger numbers of people and where face coverings can’t always be worn. This includes indoor sports and recreational fitness; indoor dining, museums, art galleries and libraries, and casinos and bingo halls, with capacity limits. The province will remain in each step for at least 21 days to evaluate any impacts on key public health and health system indicators. If at the end of the 21 days, the following vaccination thresholds have been met, along with positive trends in other key public health and health system indicators, then the province will move to the next step: • Step 1: 60 per cent of adults vaccinated with one dose. • Step 2: 70 per cent of adults vaccinated with one dose and 20 per cent vaccinated with two doses. • Step 3: 70 to 80 per cent of adults vaccinated with one dose and 25 per cent vaccinated with two doses. Learn more at ontario.ca/reopen. *NEW* City of Toronto working to reopen outdoor recreational amenities following the Province of Ontario's announcement that a number of amenities can reopen effective Saturday, May 22. Outdoor recreational amenities scheduled to reopen include golf courses, sports courts and fields, BMX and skate parks, picnic tables and shelters, outdoor fitness equipment and dry pads located at outdoor artificial ice rinks. Learn more in this news release. *NEW* Book now! Long Weekend Dose Drive vaccination appointments still available – News Release. Yesterday the City of Toronto opened 19,000 new appointments at City-run immunization clinics for the upcoming Victoria Day long weekend. Total appointments over the weekend are now 73% booked. More than 15,115 appointments are still available this long weekend. Eligible residents can book now at www.toronto.ca/covid19 or by calling 1-833-943- 3900. *NEW* Team Toronto Sprint Strategy adding seven more postal code areas for priority pop- up and mobile vaccine clinics – News Release. Team Toronto vaccination partners continue to prioritize postal code area with high rates of COVID-19 for mobile and pop-up clinics. New Sprint Strategy postal codes include M1H, M3A, M5T, M6A, M6E, M6N and M9R. *NEW* Scarborough Health Network is hosting a few Family Pop-Up Clinics this weekend for individuals aged 12+ who live or work in a Scarborough (M1) hot spot postal code. • *TODAY, May 20 | 1pm-9pm | David & Mary Thomson CI, 125 Brockley Dr • Fri, May 21 | 10am-7pm | Bamburgh Gardens Shopping Plaza, 375 Bamburgh Circle • Sat, May 22 | 9am-5pm | Malvern Christian Assembly, 6705 Sheppard Ave E • Sun, May 23 | 10am-8pm | Islamic Foundation of Toronto, 441 Nugget Ave • Sun, May 23 | 10am-8pm | Lakshmi Narayan Temple, 1 Morningview Trl Tickets will be provided for same-day appointments starting the morning of each clinic, on a first come, first served basis. These clinics will be administering first does of the Pfizer COVID- 19 vaccine. Young people must be 12 years old or older at the time of vaccination. People must bring proof of ID and address. For young people 12+, proof of ID includes a passport, PR card, report card plus ID of their parent or guardian present. OHIP is NOT required. Visit www.scarbvaccine.ca for more details and updates on Pop-Up Vaccine Clinics. Additional COVID-19 Vaccine Pop-Up Clinics: • Sat, May 22 | 8am-until supplies last | East Toronto Health Partners Drive-Thru Vaccine Clinic for Toronto Seniors ages 65+ & their caregivers ages 18+ | 705 Warden Ave (Warden Station North Parking Lot | Drive-in only. No appointment required | See this poster for more details. • Fri, May 22 | Family Friendly Clinic open to those ages 12+ living or working in ANY Toronto hotspot | Victoria Park CI, 15 Wallingford Rd | Book online| Proof of ID for children include a report card plus parent ID | See this post for more information. City of Toronto Immunization Clinic Eligibility: People ages 18+ are eligible to book a vaccination appointment. The full lust of eligible groups with information on how to register for appointments is available on the City’s COVID-19: How to Get Vaccinated webpage. Eligible individuals can book through the provincial booking system at www.toronto.ca/covid19 or by calling 1-833-943-3900. You can also visit the VaccineTO website regularly to see if local clinics have available appointments. Scarborough Health Network Community Vaccine Clinic Eligibility: People ages 18+ who are living or working in Scarborough can book a vaccination appointment at any of SHN’s community vaccine clinics. People who are ages 12+ are eligible to book a vaccination appointment at SHN’s Centennial College vaccine clinic. Proof of residency/workplace in Scarborough is required. People age 12-17 must be accompanied by a parent or guardian. For more information and to book an appointment please visit www.scarbvaccine.ca COVID-19 Pharmacy Vaccine Locations & Eligibility: Select pharmacy locations in Toronto and Peel are administering the Pfizer vaccine to individuals aged 18+. Select pharmacy locations in Durham, Hamilton, Ottawa, Windsor and York are administering the Moderna vaccine to individuals aged 18+. For more information please visit this site. Where to get accurate COVID-19 vaccine information There is a lot of incorrect information about the COVID-19 vaccines on social media and group chats, such as WhatsApp. Accurate and trusted information can be found on the City’s COVID- 19: Vaccines webpage. If you have questions about the vaccines, you should speak with your doctor or health care provider. Toronto Public Health’s COVID-19 Vaccination Town Hall for Parents/Guardians of Students (age 12-17). Dr. Vinita Dubey, Associate Medical Officer of Health, will provide a presentation and answer questions about COVID-19 vaccines available in Canada, vaccine safety and benefits, how to get vaccinated and who is eligible and ways to reduce COVID-19 spread. No registration is required. Choose from three upcoming session dates on May 25, May 26 or May 29. City of Toronto-Vaccine Hunters Canada to help residents quickly find available vaccine appointments at City-run clinics. Vaccine appointment availability at all nine City clinics and will be displayed @VaxHuntersCan. More information is available on the City website. City of Toronto COVID-19 Vaccine Clinic – Locations Map. All COVID-19 Immunization Clinics across the city, including City-run facilities, pharmacies and hospitals, are now mapped on the City’s website. Residents can search for the clinic closest to them by location or address. Additional Ward 24 specific vaccination sites can be found here. Residents must register for an appointment. Do you need help getting to your vaccination appointment? The City’s Vaccine Equity Transportation Plan is piloting transportation services for individuals age 55+ who may be unable to access or afford existing transportation options to get to their vaccination appointments. Eligible residents can book their vaccination appointment at www.toronto.ca/covid-19 then book a ride contact with Toronto Ride, iRide or Scarborough Ride. Vaccine Appointment booking for residents without OHIP Cards. Resident without OHIP cards who meet current vaccine eligibility criteria can request assistance to book their vaccination appointment at a City-run immunization clinic by contacting FCJ Refugee Centre, Access Alliance or Toronto Public Health. Residents without an OHIP card may use other forms of identification to book their COVID-19 vaccination appointment through agency partners. For more details and contact information please see this page. In-Home Vaccination for Homebound Persons If you are a homebound person receiving care through a Primary Care Provider, Family Health Team, Home or Community Care or Community Support Services or Agencies, please contact your provider to learn whether they are able to offer in-home vaccination. If you are homebound person who does not have a Primary Care Provider, Family Health Team, Home or Community Care or Community Support Services, please contact the Toronto Seniors Help Line at 416-217-2077 or by webchat at www.torontoseniorshelpline.ca/web-chat COVID-19 tests are available at assessment centres, pop-up and mobile testing facilities and pharmacies. Learn more about COVID-19 testing locations and eligibility, including locations of upcoming pop-up testing sites, by visiting toronto.ca/COVID19Testing.The website features a map to help you easily find a testing location near you. City of Toronto COVID-19 Case Update: (Data as of May 20, 2021) There has been an increase of 555 COVID-19 cases in the City with 998 people hospitalized.
Recommended publications
  • The Epidemiology of COVID-19 in Canada in 2020: the Pre-Vaccine Era February 2021
    The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era February 2021 An RSC Policy Briefing The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era An RSC Policy Briefing Authors Wendy Sligl (Chair) University of Alberta David Waldner University of Alberta Jennie Johnstone University of Toronto Robyn Harrison University of Alberta Duncan Webster Dalhousie University Lynora Saxinger University of Alberta Peer Review Monitor Tom Marrie, FRSC Dalhousie University Peer Reviewers Nick Daneman University of Toronto Rob Fowler University of Toronto Srinivas Murthy The University of British Columbia David Patrick The University of British Columbia Dan Reid Dalhousie University Robert Strang Chief Medical Officer of Health, Nova Scotia Suggested citation for Policy Briefing Report: Waldner D, Harrison R, Johnstone J, Saxinger L, Webster D, Sligl W. The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era. Royal Society of Canada. 2021 Cover Art Christine De Vuono, For Your Own Good, (2020) Over the course of the pandemic, those in long term care facilities have been hit hardest with the impact of COVID-19 outbreaks. The response has been to lock down care homes and ban visitors, volunteers and even care packages, as attempts to stop the virus from entering the facility. This had the unintended, but very real consequence of isolating our most vulnerable from those who care for and love them. “For Your Own Good”, made of 100 carved figures from identical bars of soap, then placed in mason jars, which in turn are placed on shelves, allow us to look in on the miniature elderly figures, who look out at us.
    [Show full text]
  • Celebrating 100 Years
    AMERICANa CERAMICting SOCIETY ars Celebr 100 ye bulletinemerging ceramics & glass technology JUNE/JULY 2021 Student perspectives on facing uncertainty New issue inside: JUNE/JULY 2021 • VOLUME 2 • ISSUE 2 www.ceramics.org/ceramicandglassmanufacturing PREPARING FOR CONTINGENCIES HELPED COMPANIES GROW DURING THE PANDEMIC THE ROCKY ROAD BACK TO ‘LIVE’: IMPACT OF THE PANDEMIC FROM A TRADE SHOW PERSPECTIVE Materials Genome Initiative at 10 years | 2021-2022 ACerS Board members and directors When it Comes to Heat, We Sweat the Details! Your firing needs are unique. Our laboratory can run tests to So why use an “off the shelf” help identify your process kiln in your process? boundaries. Through our toll firing facility, we can At Harrop, we get it. help to further define That’s why, for over a the equipment/ century, we’ve been processing putting in the hard work combination that to design and service works best for your custom kilns. Is it harder material. And if you to do things this way? are not ready for a Yes. Is the extra effort new kiln, we can toll worth it? You bet! fire your material to help meet your At Harrop, we don’t production needs. stop there. If you aren’t sure what you Does your current need, we can help. kiln company sweat the details? www.harropusa.com 1.614.231.3621 Harrop Ad Sweat the Details ACerS Full Size w 100 logo.indd 1 5/21/20 9:33 AM contents June/July 2021 • Vol. 100 No.5 feature articles department News & Trends . 3 Materials Genome Initiative 10 years later: Spotlight .
    [Show full text]
  • Effectiveness of Bnt162b2 and Mrna-1273 Covid-19 Vaccines BMJ: First Published As 10.1136/Bmj.N1943 on 20 August 2021
    RESEARCH Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines BMJ: first published as 10.1136/bmj.n1943 on 20 August 2021. Downloaded from against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study Hannah Chung,1 Siyi He,1 Sharifa Nasreen,1 Maria E Sundaram,1,2 Sarah A Buchan,1,2,3,4 Sarah E Wilson,1,2,3,4 Branson Chen,1 Andrew Calzavara,1 Deshayne B Fell,1,5,6 Peter C Austin,1,7 Kumanan Wilson,5,8,9 Kevin L Schwartz,1,2,3 Kevin A Brown, 1,2,3 Jonathan B Gubbay,3,10 Nicole E Basta,11 Salaheddin M Mahmud,12 Christiaan H Righolt,12 Lawrence W Svenson,13,14,15,16 Shannon E MacDonald,15,17 Naveed Z Janjua,18,19 Mina Tadrous,1,20,21 Jeffrey C Kwong,1,2,3,4,22,23 on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators For numbered affiliations see ABSTRACT received at least one dose of vaccine. Among end of the article OBJECTIVE participants who tested positive, 2479 (4.7%) were Correspondence to: J Kwong To estimate the effectiveness of mRNA covid-19 admitted to hospital or died. Vaccine effectiveness [email protected] vaccines against symptomatic infection and severe against symptomatic infection observed ≥14 days (or @DrJeffKwong on Twitter ORCID 0000-0002-7820-2046) outcomes (hospital admission or death). after one dose was 60% (95% confidence interval Additional material is published DESIGN 57% to 64%), increasing from 48% (41% to 54%) at online only.
    [Show full text]
  • April 28, 2021 Update Dear Neighbours, I Would Like to Continue
    April 28, 2021 Update Dear Neighbours, I would like to continue to thank everyone for their efforts during these difficult times. It has been difficult for everyone. We must continue to fight the spread of COVID-19 and keep ourselves and our community safe by following the public health measures in place. Remember, our mental health is paramount, we need to continue to take care of ourselves and seek support if needed. You’re Invited: Please send me your questions for Dr. Shovita Padhi on the planning of vaccination sites across the City of Toronto. To submit questions about vaccine planning and distribution, please click here. To join the meeting at the time of the event, please click here. Watch Scarborough-Guildwood’s past Live Town Hall meetings on my YouTube channel - like and subscribe for more videos! Ensure you Subscribe to the channel! The City of Toronto remains subject to a provincial wide Stay-at-Home order. The provincial wide shutdown requires all residents to remain home except for essential purposes. I encourage everyone to review the Province's COVID-19 public health measures and advice, the City’s Guide for Toronto Residents and Changes to City Services for the most up-to-date information on public health guidelines and regulations. Where to get accurate COVID-19 vaccine information There is a lot of incorrect information about the COVID-19 vaccines on social media and group chats, such as WhatsApp. Accurate and trusted information can be found on the City’s COVID- 19: Vaccines webpage. If you have questions about the vaccines, you should speak with your doctor or health care provider.
    [Show full text]
  • Hannah Jackson Amy Skinner Jeevana Rajkumar
    #PASSIONTOPURPOSE VIRTU A L YOUTH LE A DERSHIP SUMMIT ADAPT, EVOLVE AND LEAD IN A POST-PANDEMIC WORLD WELCOME 2 ABOUT 3 EVENT SCHEDULE 4 DAY 1 5 CONTENTS DAY 2 17 OF DAY 3 31 DAY 4 48 BLE A DAY 5 66 T I want to welcome you to the Passion to Purpose event 2021, hosted by The Duke of Edinburgh’s International Award - Canada, as part of the Canada Service Corps initiative. We hope that this forum does exactly as its title suggests: help to inspire and motivate you to turn whatever you are passionate about into something purposeful, something that helps your community, however you wish to define that term.If you are attending this conference you have expressed a desire to take on a role as a Leader in your community. This forum is designed to encourage you to identify the skills, attributes and drivers that might make you more successful in this leadership role. Successful in the sense of drawing others into your project, engaging fully with partners and others members of our wonderful civil society amd WELCOME ensuring that what you set out to achieve has real community impact. I hope you enjoy your initial experience and are able to take away from this week something that helps you build a future of which you are proud to be a part and for which you can feel responsible. Stephen De-Wint National Executive Director The Duke of Edinburgh’s International Award - Canada 2 PASSION TO PURPOSE Passion to Purpose (P2P) is a comprehensive, youth forum that is designed to foster community service through civic leadership in young Canadians.
    [Show full text]
  • Debates of the House of Commons
    43rd PARLIAMENT, 2nd SESSION House of Commons Debates Official Report (Hansard) Volume 150 No. 083 Monday, April 19, 2021 Speaker: The Honourable Anthony Rota CONTENTS (Table of Contents appears at back of this issue.) 5773 HOUSE OF COMMONS Monday, April 19, 2021 The House met at 11 a.m. members to be mindful of their words, which may be heard by oth‐ er members and by many Canadians as being offensive. ● (1105) Prayer The Speaker: I want to thank the hon. member for his point of order. I take it under advisement. I will return to the House with a ● (1100) ruling on that. [English] POINTS OF ORDER PRIVATE MEMBERS' BUSINESS COMMENTS BY THE MEMBER FOR CLOVERDALE—LANGLEY CITY [Translation] Mr. Robert Oliphant (Parliamentary Secretary to the Minis‐ ter of Foreign Affairs, Lib.): Mr. Speaker, I rise on a point of or‐ EMPLOYMENT INSURANCE ACT der. Mrs. Claude DeBellefeuille (Salaberry—Suroît, BQ) moved On Friday, April 16, at the last sitting of this House, we had de‐ that Bill C-265, An Act to amend the Employment Insurance Act bate on Bill C-6, an act to amend the Criminal Code, conversion (illness, injury or quarantine), be read the second time and referred therapy. During the question-and-answer period following my to a committee. speech opening the morning's debate, contrary to Standing Order She said: Mr. Speaker, this is it. We made it. It is finally time to 18, the member for Cloverdale—Langley City used language that debate a very compassionate, common-sense bill that seeks to ex‐ was offensive to me and, in my understanding, to many other mem‐ tend special employment insurance sickness benefits from bers of the House.
    [Show full text]
  • Horizon Scanning Status Report December 2020
    PCORI Health Care Horizon Scanning System Volume 2 Issue 4 Horizon Scanning Status Report December 2020 Prepared for: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036 Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12 Prepared by: ECRI Institute 5200 Butler Pike Plymouth Meeting, PA 19462 Investigators: Randy Hulshizer, MA, MS Damian Carlson, MS Christian Cuevas, PhD Andrea Druga, MSPAS, PA-C Marcus Lynch, PhD, MBA Misha Mehta, MS Prital Patel, MPH Brian Wilkinson, MA Donna Beales, MLIS Jennifer De Lurio, MS Eloise DeHaan, BS Eileen Erinoff, MSLIS Cassia Hulshizer, BBA Madison Kimball, MS Maria Middleton, MPH Melinda Rossi, BS Diane Robertson, BA Kelley Tipton, MPH Rosemary Walker, MLIS Andrew Furman, MD, MMM, FACEP Statement of Funding and Purpose This report incorporates data collected during implementation of the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System, operated by ECRI under contract to PCORI, Washington, DC (Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12). The findings and conclusions in this document are those of the authors, who are responsible for its content. No statement in this report should be construed as an official position of PCORI. An intervention that potentially meets inclusion criteria might not appear in this report simply because the Horizon Scanning System has not yet detected it or it does not yet meet the inclusion criteria outlined in the PCORI Health Care Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Inclusion or absence of interventions in the horizon scanning reports will change over time as new information is collected; therefore, inclusion or absence should not be construed as either an endorsement or a rejection of specific interventions.
    [Show full text]
  • The Innovation Awards 2020
    DECEMBER 2020 # 71 In My View Feature Best Practice NextGen The benefits of 3D printing How far have we come Top tips for E&L Reviewing setbacks and for biopharma against COVID-19? analysis successes in gene therapy 10 24 – 31 36 – 39 46 – 49 The Innovation Awards 2020 Celebrating 2020’s top pharma development and manufacturing technologies 14 – 21 www.themedicinemaker.com Do You Want to Learn More About monoclonal Antibody Production? Today’s bioprocess professionals need to stay on top of many things: Scale-up parameters and equipment capabilities, control strategies and automation, validation requirements and docu- mentation to name a few. New fields of applications like stem cell technology are evolving into powerful tools of the future. Become a bioprocessing. Join us at www.eppendorf.com/bioprocess Eppendorf® and the Eppendorf Brand Design are registered trademarks of Eppendorf AG, Germany. www.eppendorf.com /bioprocess All rights reserved, including graphics and images. Copyright © 2020 by Eppendorf AG. Is it Time to Reevaluate Our Priorities? The COVID-19 vaccines demonstrate what’s possible Editorial when disease is tackled as a genuine priority he whole research and development community is working hard to bring us that [COVID-19] breakthrough sooner rather than later,” wrote TStephanie Sutton in her November editorial (1). And here we are, just one month later, with not one but three breakthroughs. Pfizer (2) and Moderna (3) are both claiming around 95 percent efficacy in their vaccine studies, involving 44,000 and 30,000 volunteers respectively. And then we had AstraZeneca and the University of Oxford announcing that their vaccine, which should be cheaper and easier to distribute than the aforementioned mRNA approaches, is 70 percent effective (4).
    [Show full text]
  • COVID-19 and the State of Global Mobility in 2020
    COVID-19 and the State of Global Mobility in 2020 Meghan Benton Jeanne Batalova Samuel Davidoff-Gore Timo Schmidt The opinions expressed in the report are those of the authors and do not necessarily reflect the views of the International Organization for Migration (IOM). The designations employed and the presentation of material throughout the report do not imply expression of any opinion whatsoever on the part of IOM concerning legal status of any country, territory, city or area, or of its authorities, or concerning its frontiers or boundaries. IOM is committed to the principle that humane and orderly migration benefits migrants and society. As an intergovernmental organization, IOM acts with its partners in the international community to: assist in meeting the operational challenges of migration; advance understanding of migration issues; encourage social and economic development through migration; and uphold the human dignity and well-being of migrants. The Migration Policy Institute (MPI) is an independent, nonpartisan think tank that seeks to improve immigration and integration policies through authoritative research and analysis, opportunities for learning and dialogue, and the development of new ideas to address complex policy questions. MPI is an independent, nonpartisan policy research organization that adheres to the highest standard of rigor and integrity in its work. All analysis, recommendations and policy ideas advanced by MPI are solely determined by its researchers. This publication was made possible through support provided by the German Federal Foreign Office. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the German Federal Foreign Office. Publisher: International Organization for Migration Publisher: Migration Policy Institute 17 Route des Morillons 1400 16th St NW P.O.
    [Show full text]
  • Downloaded Or Used a Contact Tracing/Exposure Notification App (77%) and Who Would Not Receive a COVID-19 Vaccine When Available (20%) Or Were Unsure (12%)
    COVID-19 Evidence Support Team EVIDENCE SEARCH REPORT Review Question: How effective are COVID-19 vaccines? Context: Benefits following dose/second dose; how well it prevents infections; evidence of limiting viral replication or spread; preventing hospitalization; preventing ventilation; preventing “long COVID” (long term symptoms), duration of immunity (natural and vaccinated). FDA cold chain changes. Effectiveness against P1 variant. Booster doses for variants. Does not include vaccine willingness/acceptance (to be run as a separate search) Review Code: INF031801v3 ESR Complete Date: April 30, 2021 Cite As: Miller, L., Howell-Spooner, B.. How effective are COVID-19 vaccines? 2021 Apr 30, Document no.: INF031801v3 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. 107 p. (CEST evidence search report). Librarian Notes & Comments Hello All, We’ve run this update for the databases from March 18th to April 30th, and searched for grey literature between those dates as well. Thanks, Brianna and Lukas Search Results: Guidelines, Summaries & Other Grey Literature Government Health Canada Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply. April 14, 2021. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee- on-immunization-naci/extended-dose-intervals-covid-19-vaccines-early-rollout-population- protection.html Public Health Agency of Canada Disclaimer This information is provided as a service by the Saskatchewan Health Authority and University of Saskatchewan Libraries. Professional librarians conduct searches of the literature. Results are subject to the limitations of the databases and the specificity, broadness and appropriateness of the search parameters presented by the requester.
    [Show full text]
  • Non-Viral COVID-19 Vaccine Delivery Systems
    Advanced Drug Delivery Reviews 169 (2021) 137–151 Contents lists available at ScienceDirect Advanced Drug Delivery Reviews journal homepage: www.elsevier.com/locate/addr Non-viral COVID-19 vaccine delivery systems Kyung Soo Park a,b,1, Xiaoqi Sun b,c,1, Marisa E. Aikins b,c,1, James J. Moon a,b,c,⁎ a Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA b Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA c Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA article info abstract Article history: The novel corona virus termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread Received 10 October 2020 throughout the globe at a formidable speed, causing tens of millions of cases and more than one million deaths Received in revised form 20 November 2020 in less than a year of its report in December 2019. Since then, companies and research institutions have raced Accepted 13 December 2020 to develop SARS-CoV-2 vaccines, ranging from conventional viral and protein-based vaccines to those that are Available online 17 December 2020 more cutting edge, including DNA- and mRNA-based vaccines. Each vaccine exhibits a different potency and du- ration of efficacy, as determined by the antigen design, adjuvant molecules, vaccine delivery platforms, and im- munization method. In this review, we will introduce a few of the leading non-viral vaccines that are under clinical stage development and discuss delivery strategies to improve vaccine efficacy, duration of protection, safety, and mass vaccination. ©2020ElsevierB.V.Allrightsreserved.
    [Show full text]
  • Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
    COVID-19 Treatment Guidelines Coronavirus Disease 2019 (COVID-19) Treatment Guidelines Credit NIAID-RML Downloaded from https://www.covid19treatmentguidelines.nih.gov/ on 9/25/2021 Visit https://www.covid19treatmentguidelines.nih.gov/ to access the most up-to-date guideline. How to Cite the COVID-19 Treatment Guidelines: COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed [insert date]. The COVID-19 Treatment Guidelines Panel regularly updates the recommendations in these guidelines as new information on the management of COVID-19 becomes available. The most recent version of the guidelines can be found on the COVID-19 Treatment Guidelines website (https://www.covid19treatmentguidelines.nih.gov/). Downloaded from https://www.covid19treatmentguidelines.nih.gov/ on 9/25/2021 Table of Contents What’s New in the Guidelines .................................................................................................. 5 The COVID-19 Treatment Guidelines Panel’s Statement on Bamlanivimab Plus Etesevimab for the Treatment of Mild to Moderate COVID-19 in Nonhospitalized Patients ..... 8 The COVID-19 Treatment Guidelines Panel’s Statement on the Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment or Prevention of SARS-CoV-2 Infection When There Are Logistical Constraints ...................................................................... 9 The COVID-19 Treatment Guidelines
    [Show full text]